Antiviral Drugs Advisory Committee

August 6, 2002 Meeting

Consultants and Guests

 

Consultants (voting)

F. Blaine Hollinger, M.D. (Consultant – Center for Biologics Evaluation and Research)
Professor of Medicine, Virology & Epidemiology
Director, Eugene B. Casey Hepatitis & HIV Research Center and Diagnostic Laboratory
Baylor College of Medicine
One Baylor Plaza
Houston, Texas 77030

Jeffrey Kopp, M.D.
Kidney Disease Section
NIDDK, NIH
Bldg. 10, Rm. 3N116
Bethesda, Maryland 20892

W. Thomas London, M.D.
Senior Member, Division of Population Science
Fox Chase Cancer Center
7701 Burholme Avenue
Philadelphia, Pennsylvania 19111

Maria H. Sjogren, M.D. (Member – Gastrointestinal Drugs Advisory Committee)
Chief, Department of Clinical Investigation
Walter Reed Army Medical Center
6825 16th Street, N.W.
Washington, DC 20307

Samuel So, M.D.
Director, Asian Liver Center
Director, Liver Cancer Program
Associate Professor of Surgery
Stanford University School of Medicine
300 Pasteur Drive, H3680
Stanford, California 94305

Consultant (non-voting) – Pending New AVAC Member

Kenneth E. Sherman, M.D., Ph.D.
Director, Hepatology & Liver Transplant Medicine Section
Associate Professor of Medicine
Division of Digestive Diseases
University of Cincinnati College of Medicine
231 Albert B. Sabin Way, ML 0595
Cincinnati, Ohio 45267

Industry Representative (non-voting)

Eugene Sun, M.D.
Abbott Laboratories
200 Abbott Park Road
Department 48U / Building AP30-3
Abbott Park, Illinois 60064-6146

Patient Representative (non-voting)

Brett Grodeck
Hepatitis B Action Coalition
938 3rd Street, #306
Santa Monica, California 90403